EUVIMEDEUVIMED entdecken
Crossref

Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity

Héctor Gaitán-Peñas iD, Salomé Llabrés iD, Marina Pedrola iD, Marc González-Subías iD, Jordi Juárez-Jiménez iD, Michael Pusch iD, Rodolfo Lavilla iD, Raúl Estévez iD

Journal of General Physiology · 2026

DOI: 10.1085/jgp.202513953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Physiology, 2026. Verfasst von Héctor Gaitán-Peñas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Unit, Department of Physiological Sciences, School of Medicine and Health Sciences, Institute of Neurosciences, Universitat de Barcelona, …. Hauptthemen laut MEDLINE: Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Fondo Europeo de Desarrollo Regional, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The volume-regulated anion channel (VRAC), formed by LRRC8 heteromers, regulates cell volume and is a promising therapeutic target. DCPIB is the most widely used VRAC inhibitor, yet its binding mechanism remains poorly defined. Although structural studies suggested a role of residue R103 in LRRC8A in DCPIB binding, its functional relevance has been unclear. Here, we combined electrophysiology in Xenopus oocytes and LRRC8−/− HEK293T cells with MD simulations and rational design of DCPIB analogs. Mutations of R103 abolished ATP-dependent block of VRAC but did not affect inhibition by DCPIB or the related inhibitor carbenoxolone (CBX), indicating distinct binding mechanisms. Simulations revealed two DCPIB-binding modes: one involving R103 and another engaging K51 and hydrophobic residues. In R103F mutants, DCPIB retained binding via π-stacking and alternative electrostatic contacts, explaining its persistent inhibition. Attempts to disrupt these interactions by mutating K51 led to nonfunctional channels. To further probe the role of electrostatic groups in the binding of DCPIB to VRAC, we synthesized derivatives varying charge and hydrophobicity. Functional assays and steered MD showed that analogs retaining the carboxylate group maintain high-affinity binding, whereas esterified forms exhibit rapid unbinding and reduced potency. Biphenyl substitutions increased binding energy but imposed steric penalties, suggesting a trade-off between affinity and accessibility. Our findings reveal an adaptable binding mechanism for DCPIB, contrasting with described lipid-displacement mechanisms for other VRAC inhibitors, and establish electrostatic complementarity as the primary determinant of high-affinity block. These insights provide a framework for rational design of next-generation VRAC inhibitors with improved specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsAnimalsHumansStatic ElectricityHEK293 CellsProtein BindingOocytesMutationMolecular Dynamics SimulationXenopus laevisCyclopentanesIndans

Substanzen

4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-one-5-yl)oxybutyric acidMembrane ProteinsCyclopentanesIndans

Autor:innen und Institutionen

  • Physiology Unit, Department of Physiological Sciences, School of Medicine and Health Sciences, Institute of Neurosciences, Universitat de Barcelona, L'Hospitalet de Llobregat, Spain.
  • Neuroscience Program, Physiology and Pathology of the Functional Relationship Between Glia and Neurons-IDIBELL , L'Hospitalet de Llobregat, Spain.
  • Department of Cell Biology, Physiology and Immunology, Medical Physiology Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain.
  • Unitat de Fisicoquímica, Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
  • Institut de Química Teòrica i Computacional (IQTC), Facultat de Química i Física, Universitat de Barcelona , Barcelona, Spain.
  • Laboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences and Institute of Biomedicine (IBUB), Universitat de Barcelona , Barcelona, Spain.

ORCID-Profile: Héctor Gaitán-Peñas, Salomé Llabrés, Marina Pedrola, Marc González-Subías, Jordi Juárez-Jiménez, Michael Pusch, Rodolfo Lavilla, Raúl Estévez

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Fondo Europeo de Desarrollo Regional
  • Generalitat de Catalunya
  • Marató TV3 project
  • Institut de Química Teòrica i computational
  • Consorci de Serveis Universitaris de Catalunya
  • Ministerio de Ciencia e Innovación
  • Agencia Estatal de Investigación

Zitieren

APA

Gaitán-Peñas, H., Llabrés, S., Pedrola, M., González-Subías, M., Juárez-Jiménez, J., Pusch, M., Lavilla, R., & Estévez, R. (2026). Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity. Journal of General Physiology. https://doi.org/10.1085/jgp.202513953

Vancouver

Gaitán-Peñas H, Llabrés S, Pedrola M, González-Subías M, Juárez-Jiménez J, Pusch M, et al. Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity. Journal of General Physiology. 2026. doi:10.1085/jgp.202513953

BibTeX
@article{GaitnPeas2026,
  author = {Gaitán-Peñas, Héctor and Llabrés, Salomé and Pedrola, Marina and González-Subías, Marc and Juárez-Jiménez, Jordi and Pusch, Michael and Lavilla, Rodolfo and Estévez, Raúl},
  title = {Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity},
  journal = {Journal of General Physiology},
  year = {2026},
  doi = {10.1085/jgp.202513953}
}
Kostenlos starten →